Clare Market Investments LLC Invests $624,000 in Corteva, Inc. $CTVA

Clare Market Investments LLC purchased a new position in shares of Corteva, Inc. (NYSE:CTVA) in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 7,450 shares of the company’s stock, valued at approximately $624,000.

Other institutional investors also recently added to or reduced their stakes in the company. Harris Associates L P lifted its holdings in shares of Corteva by 168.1% in the 4th quarter. Harris Associates L P now owns 17,026,221 shares of the company’s stock valued at $1,141,268,000 after buying an additional 10,675,052 shares during the period. Norges Bank purchased a new stake in shares of Corteva during the 4th quarter worth $504,001,000. Northwestern Mutual Wealth Management Co. grew its stake in shares of Corteva by 6,527.4% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 3,148,212 shares of the company’s stock worth $211,025,000 after purchasing an additional 3,100,709 shares during the period. Perpetual Ltd increased its holdings in shares of Corteva by 78,688.5% in the 4th quarter. Perpetual Ltd now owns 2,615,779 shares of the company’s stock valued at $175,336,000 after purchasing an additional 2,612,459 shares in the last quarter. Finally, Amundi boosted its holdings in Corteva by 125.3% during the third quarter. Amundi now owns 3,415,554 shares of the company’s stock worth $219,620,000 after buying an additional 1,899,248 shares in the last quarter. Hedge funds and other institutional investors own 81.54% of the company’s stock.

Corteva Stock Performance

Corteva stock opened at $87.34 on Tuesday. Corteva, Inc. has a fifty-two week low of $60.53 and a fifty-two week high of $87.18. The company has a market capitalization of $58.41 billion, a price-to-earnings ratio of 51.35, a PEG ratio of 2.62 and a beta of 0.56. The stock has a fifty day moving average of $79.80 and a two-hundred day moving average of $76.94. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.03 and a current ratio of 1.47.

Corteva (NYSE:CTVA) last issued its quarterly earnings data on Tuesday, May 5th. The company reported $1.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.18 by $0.32. The business had revenue of $4.91 billion for the quarter, compared to the consensus estimate of $4.64 billion. Corteva had a return on equity of 9.95% and a net margin of 6.50%.The business’s revenue was up 11.0% on a year-over-year basis. During the same period in the prior year, the business earned $1.13 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, analysts anticipate that Corteva, Inc. will post 3.72 EPS for the current fiscal year.

Corteva Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, June 15th. Stockholders of record on Monday, June 1st were issued a dividend of $0.18 per share. The ex-dividend date was Monday, June 1st. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.8%. Corteva’s payout ratio is 42.35%.

Analysts Set New Price Targets

A number of research firms have recently issued reports on CTVA. CICC Research lifted their price target on shares of Corteva from $80.00 to $93.00 and gave the company an “outperform” rating in a research report on Wednesday, May 13th. Mizuho raised their price objective on Corteva from $94.00 to $96.00 and gave the company an “outperform” rating in a research note on Thursday, July 2nd. The Goldman Sachs Group boosted their target price on Corteva from $88.00 to $96.00 and gave the stock a “buy” rating in a research report on Tuesday, April 14th. Oppenheimer lifted their price target on Corteva from $86.00 to $89.00 and gave the stock an “outperform” rating in a research note on Wednesday, April 22nd. Finally, BNP Paribas Exane boosted their price objective on shares of Corteva from $74.00 to $77.00 in a research report on Wednesday, May 6th. Fourteen equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. Based on data from MarketBeat, Corteva presently has an average rating of “Moderate Buy” and an average price target of $88.90.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.